D.A. Davidson Acts as Financial Advisor to Eskola Roofing & Waterproofing on Its Majority Equity Investment from Eagle Merchant Partners | National Business

D.A. Davidson Acts as Financial Advisor to Eskola Roofing & Waterproofing on Its Majority Equity Investment from Eagle Merchant Partners | National Business

ATLANTA–(BUSINESS WIRE)–Nov 2, 2022– D.A. Davidson & Co. announced today that it served as exclusive financial advisor to Eskola Roofing & Waterproofing (Eskola) on its majority recapitalization with Eagle Merchant Partners (Eagle). Eskola is a commercial roofing contractor with four Tennessee locations, Knoxville, Nashville, Morristown, and Memphis, and a fifth location in Lexington, Kentucky. This…

Read More
ADMA Biologics Pronounces 2d Quarter 2022 Monetary Effects and Supplies Industry Replace

ADMA Biologics Pronounces 2d Quarter 2022 Monetary Effects and Supplies Industry Replace

ADMA Biologics, Inc. 2Q2022 Overall Revenues Have been $33.9 Million, a 90% Y-o-Y Building up Grew 2Q2022 Gross Benefit to $7.8 Million, Up 112% Over 1Q2022 Narrowed 2Q2022 Web Losses to $13.8 Million, a forty five% Growth Over 1Q2022 Complete Yr 2022 Overall Revenues Anticipated to Exceed $130 Million Gross Margin Expansion and Narrowing Web…

Read More
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update

POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update

POINT Biopharma Reported 27-patient dosimetry data from the lead-in cohort of the SPLASH trial Randomization phase of SPLASH trial ongoing, top line data expected mid-2023 Phase 1 therapeutic trial for PNT6555, the lead of the pan-cancer PNT2004 fibroblast activation protein-alpha (FAP-alpha) inhibitor program, planned for summer 2022 Indianapolis radiopharmaceutical manufacturing facility operational and supplying doses…

Read More